Evidence map›Paper›PMID 34471387›Full record

ArticleClinical epidemiology2021

Quality and Completeness of Myocardial Infarction Recording in Clinical Practice Research Datalink Aurum.

Rebecca Persson, Todd Sponholtz, Catherine Vasilakis-Scaramozza, Katrina Wilcox Hagberg, Tim Williams, Dipak Kotecha, Puja Myles, Susan S Jick

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Rebecca PerssonEpidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.
Todd SponholtzEpidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.
Catherine Vasilakis-ScaramozzaEpidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.
Katrina Wilcox HagbergEpidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.ORCID 0000-0002-2407-2995
Tim WilliamsClinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK.
Dipak KotechaInstitute of Cardiovascular Sciences, University of Birmingham & University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Puja MylesClinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK.ORCID 0000-0002-8976-890X
Susan S JickEpidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.ORCID 0000-0002-2215-1067
Boston Collaborative Drug Surveillance Program · USClinical Practice Research Datalink · GBBoston University · USUniversity Hospitals Birmingham NHS Foundation Trust · GB

Funding

British Heart Foundation PG/17/55/33087
6 · The paper itself

Abstract

backgroundValidation studies of the Clinical Practice Research Datalink (CPRD) Aurum database in the UK are critical for making decisions about its suitability and validity for research purposes.

objectiveTo examine data source agreement of myocardial infarction (MI) diagnoses recorded in CPRD Aurum compared with linked Hospital Episode Statistics (HES) data. This comparison provides information on CPRD Aurum data correctness (accuracy, validity) and completeness (presence, missingness).

methodsPatients with MI diagnoses recorded in either data source were selected from a random sample of 50,000 patients in CPRD Aurum with HES linkage (1997-2017). Correctness was defined as the proportion of MI cases in CPRD Aurum with a concordant MI diagnosis recorded in HES or with strong supporting evidence in either data source. Completeness was defined as the proportion of patients with primary HES-coded MIs with strong supporting evidence that were also present in CPRD Aurum.

resultsThere were 1260 patients with MI recorded in the CPRD Aurum sample. The overall correctness of the recorded MI diagnoses was 94%: 986 patients (78%) had concordant diagnoses in HES within 90 days; 123 (10%) were concordant with HES, but with an inconclusive date and another 71 (6%) had strong supporting evidence for being a true MI case. There were 1125 patients with MI recorded in HES primary diagnosis fields with strong supporting evidence in either data source. Of these, 880 (78%) were present in CPRD Aurum, with completeness somewhat higher in more recent years.

conclusionMI diagnoses recorded in CPRD Aurum were highly likely to be correct, supporting its use in clinical research studies. Completeness was lower, indicating the need for data linkage for some studies.

Indexed as

clinical practice research datalinkCPRD Aurumdata completenessdata qualitydata validation

Identifiers

PMID34471387
PMCPMC8403723
OpenAlexW3195196881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.